Rock Creek Pharmaceuticals, Inc. announced that the company has made a key independent appointment to the company's Board of Directors with the recent election of Dr. Sunitha Chundru Samuel as a new director. Dr. Samuel has been the Chief Executive Officer of Sierra Molecular Corporation, where Dr. Samuel also serves on its board of directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2020 | Rock Creek Pharmaceuticals, Inc. Went Out of Business | CI |
2020 | Bankruptcy Judge Changed for Rock Creek Pharmaceuticals, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 17.04K | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.09% | 238B | |
+6.99% | 204B | |
-6.50% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- RCPIQ Stock
- News Rock Creek Pharmaceuticals, Inc.
- Rock Creek Pharmaceuticals, Inc. Appoints Sunitha Chundru Samuel as Director